期刊文献+

重症医院获得性肺炎患者下呼吸道微生物群落组成

Analysis of microbial community composition of lower respiratory tract in patients with severe hospital-acquired pneumonia in critical care
暂未订购
导出
摘要 目的利用宏基因组新一代测序(mNGS)了解重症监护病房(ICU)中重症医院获得性肺炎(SHAP)患者的下呼吸道微生物群落结构。方法对84例SHAP患者的支气管肺泡灌洗液(BALF)进行宏基因组新一代测序(mNGS)。根据年龄、吸烟、基础疾病、人工气道时长进行分组,比较不同组别患者气道微生物的α多样性、β多样性、微生物组成和群落结构差异,筛选人工气道差异微生物,构建网络共现图观察微生物间的相互作用。结果α多样性分析显示,青年人的微生物群落多样性和均匀度显著高于中年人,合并脑卒中的微生物多样性和均匀度下降;人工气道治疗分组中,微生物的多样性和均匀度随人工气道治疗时长的增加而降低,人工气道治疗>3 d的多样性最低。β多样性分析显示,人工气道治疗>3 d的微生物群落结构与未行人工气道治疗组、人工气道治疗≤3 d组存在显著差异。下呼吸道微生物组成分析结果显示,鲍曼不动杆菌在所有组别中占据主导地位,中年组、非吸烟组、未行人工气道治疗组、无糖尿病组、人工气道治疗>3 d组和合并慢性肺部疾病组的菌群多样性较高,特别是铜绿假单胞菌、纹带棒杆菌、小韦荣球菌在这些组别中富集。差异分析显示人工气道治疗>3 d组和未行人工气道治疗组、人工气道治疗≤3 d组在铜绿假单胞菌和纹带棒杆菌存在显著差异。网络共现图显示部分微生物间可能存在协同作用或拮抗关系。结论SHAP患者的下呼吸道微生物多样性在老年人、合并脑卒中和接受人工气道治疗的人群中明显下降,这类人群应合理使用抗菌药物,指导精准抗感染治疗。 Objective To investigae microbial community structure of lower respiratory tract in severe hospital-acquired pneumonia(SHAP)patients in intensive care unit(ICU)using metagenomic next-generation sequencing(mNGS).Methods mNGS was performed on bronchoalveolar lavage fluid(BALF)of 84 patients with SHAP.Patients were grouped based on age,smoking status,underlying diseases and duration of artificial airway.The differences inαdiversity,βdiversity,microbial composition and community structure of airway microbiota were compared between different groups.The differential airway microbiota associated with artificial airway were screened,and microbial co-occurrence networks was constructed to observe the interaction in microorganisms.Results Results ofαdiversity analysis revealed that diversity and evenness of the microbial community were higher in young adults compared to those of middle-aged patients,while microbial diversity and evenness were significantly reduced in patients with comorbid stroke.In the group of artificial airway treatment,the diversity and uniformity of microorganisms decreased as the duration of artificial airway treatment increased.The diversity was the lowest when the artificial airway treatment lasted for more than 3 days.βdiversity analysis confirmed that there were significant differences in the distinct microbial community structures between the>3 days support group and the non-intubated and≤3 days support cohorts.Acinetobacter baumannii was dominant in all groups.The bacterial diversity was significantly higher in the middle-aged group,the non-smoking group,the group without artificial airway therapy,the group without diabetes mellitus,the group with artificial airway therapy≥3 days and the group with chronic lung disease than those of other groups.In particular,pseudomonas aeruginosa,corynebacterium striatum and veillonella parvula were enriched in these groups.Difference analysis showed that there were significant differences in pseudomonas aeruginosa and corynebacterium striatum between the group with artificial airway treatment>3 days,the group without artificial airway therapy and the group with artificial airway treatment≤3 days.Network co-occurrence showed that there may be synergistic or antagonistic relationships between some microorganisms.Conclusion The microbial diversity of the lower respiratory tract in patients with SHAP significantly decreases in the elderly,those with concurrent stroke and those receiving artificial airway treatment.For these groups,rational use of antibiotics should be adopted to guide precise anti-infection treatment.
作者 郑童童 王敏 单琦 李名航 柏亚真 富奇志 ZHENG Tongtong;WANG Min;SHAN Qi;LI Minghang;BAI Yazhen;FU Qizhi(Clinical Medical College of Henan University of Science and Technology,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471003,China;Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Henan University of Science and Technology;Department of Critical Care Medicine,the First Affiliated Hospital of Henan University of Science and Technology;Department of Neurology,Luoyang Central Hospital)
出处 《天津医药》 2025年第11期1145-1151,共7页 Tianjin Medical Journal
基金 河南省医学科技攻关计划省部共建青年项目(SBGJ202303042)。
关键词 肺炎 支气管肺泡灌洗液 微生物 宏基因组新一代测序 pneumonia bronchoalveolar lavage fluid microorganism metagenomic next-generation sequencing
  • 相关文献

参考文献2

二级参考文献67

  • 1何礼贤,潘珏,陈世耀,王爱霞,谢灿茂,申正义.替考拉宁治疗革兰阳性球菌感染的临床研究[J].中华内科杂志,2005,44(5):337-341. 被引量:30
  • 2中华医学会重症医学分会,马晓春,王辰,方强,刘大为,邱海波,秦英智,席修明,黎毅敏.急性肺损伤/急性呼吸窘迫综合征诊断和治疗指南(2006)[J].中国危重病急救医学,2006,18(12):706-710.
  • 3王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 4任南,文细毛,吴安华.全国医院感染横断面调查结果的变化趋势研究[J].中国感染控制杂志,2007,6(1):16-18. 被引量:353
  • 5Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med, 2002,165 : 867-903.
  • 6Fagon JY, Chastre J, Hance A J, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med, 1993,94:281-288.
  • 7Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of pneumonia in a large US database. Chest, 2002,122 : 2115-2121.
  • 8Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med, 2005, 33 : 2184-2193.
  • 9Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest, 1997, 111: 676-685.
  • 10Horan TC, Gaynes RP. Surveillance of nosocomial infections. In : Hospital Epidemiology and Infection Control, 3rd ed. Mayhall CG, editor. Philadelphia: Lippincott Williams & Wilkins, 2004: 1659-1702.

共引文献1819

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部